Avient

AVNT · NYSE

$40.35+$0.84 (+2.13%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $39.51

AVNT analyst rating

BuyConsensus of 5 analysts over the last 12 months. 80% rate it a buy.

Strong buy0
Buy4
Hold1
Underperform0
Sell0

12-month price target · 11 analysts

Average $51.09 (+26.6% upside)

Low: $45.26
Now: $40.35
High: $58.80

Upgrades and downgrades

The latest rating actions, newest first

AVNT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barclays	Oct 13, 2026	Initiates	Equal-Weight	$44.00	50%
Wells Fargo	Aug 7, 2026	Maintains	Overweight	$47.00 → $48.00	33%
Truist Securities	Aug 7, 2026	Maintains	Buy	$44.00 → $50.00	43%
Truist Securities	Jun 8, 2026	Initiates	Buy	$44.00	43%
Keybanc	Mar 4, 2026	Downgrade	Overweight → Sector Weight	—	50%
Wells Fargo	Feb 13, 2026	Maintains	Overweight	$42.00 → $47.00	48%
Keybanc	Feb 13, 2026	Maintains	Overweight	$50.00 → $56.00	50%
Oppenheimer	Jan 20, 2026	Maintains	Outperform	$37.00 → $41.00	55%
Keybanc	Jan 9, 2026	Maintains	Overweight	$48.00 → $50.00	50%

The case for and against

Updated Feb 9, 2026

Bull case

Avient Corp has experienced a 5% increase in organic sales, indicating a robust demand for its product offerings in the Color, Additives and Inks, and Specialty Engineered Materials segments. Notably, the healthcare sector has shown impressive growth, with sales rising 14% year-over-year in the first half of 2025, sustained by double-digit growth for six consecutive quarters. Additionally, four out of nine end markets, which account for 40% of the company’s sales, are demonstrating growth this year, suggesting a diversified portfolio positioned favorably against ongoing market trends.

Bear case

Avient Corp has experienced a decline in organic sales, starting with a 2% decrease in the first quarter of 2024, followed by fluctuations in subsequent quarters that suggest inconsistent demand recovery. The company's performance in the chemicals sector has been adversely affected by weakening demand since mid-2025, raising concerns about potential volume risks in the second half of that year. Despite a favorable exchange rate environment from a declining U.S. dollar, the underlying negative trends in sales and demand do not provide a strong foundation for positive growth prospects.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.